Pathogenesis of Kupffer Cells in Cholestatic Liver Injury

American Journal of Pathology

Volumn 186, Issue 9, 2016, Pages 2238-2247

  Sato, Keisaku ^a,b,c   Hall, Chad ^b,c   Glaser, Shannon ^a,b,c   Francis, Heather ^a,b,c   Meng, Fanyin ^a,b,c   Alpini, Gianfranco ^a,b,c  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b TEXAS A AND M HEALTH SCIENCE CENTER   (United States)

^c SCOTT AND WHITE MEMORIAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 1; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 6; TUMOR NECROSIS FACTOR;

BACTERIAL CLEARANCE; BONE MARROW DERIVED MACROPHAGE; CELL ACTIVATION; CELL HETEROGENEITY; CELL PROTECTION; CHOLESTATIC LIVER INJURY; CYTOKINE PRODUCTION; HUMAN; IMMUNOPATHOLOGY; KUPFFER CELL; LIVER CELL; LIVER INJURY; MACROPHAGE; NONHUMAN; OBSTRUCTIVE BILE DUCT DISEASE; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; ANIMAL; CHOLESTASIS; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY;

ANIMALS; CHOLESTASIS; HUMANS; KUPFFER CELLS;

EID: 84995654994     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.1016/j.ajpath.2016.06.003     Document Type: Review

References (100)

1. 1 Gao, B., Jeong, W.I., Tian, Z., Liver: an organ with predominant innate immunity. Hepatology 47 (2008), 729–736.
2. 2 MacPhee, P.J., Schmidt, E.E., Groom, A.C., Evidence for Kupffer cell migration along liver sinusoids, from high-resolution in vivo microscopy. Am J Physiol 263 (1992), G17–G23.
3. 3 Smedsrod, B., De Bleser, P.J., Braet, F., Lovisetti, P., Vanderkerken, K., Wisse, E., Geerts, A., Cell biology of liver endothelial and Kupffer cells. Gut 35 (1994), 1509–1516.
4. 4 Gossard, A.A., Talwalkar, J.A., Cholestatic liver disease. Med Clin North Am 98 (2014), 73–85.
5. 5 Faubion, W.A., Guicciardi, M.E., Miyoshi, H., Bronk, S.F., Roberts, P.J., Svingen, P.A., Kaufmann, S.H., Gores, G.J., Toxic bile salts induce rodent hepatocyte apoptosis via direct activation of Fas. J Clin Invest 103 (1999), 137–145.
6. 6 Xia, X., Francis, H., Glaser, S., Alpini, G., LeSage, G., Bile acid interactions with cholangiocytes. World J Gastroenterol 12 (2006), 3553–3563.
7. 7 Jones, H., Alpini, G., Francis, H., Bile acid signaling and biliary functions. Acta Pharm Sin B 5 (2015), 123–128.
8. 8 Alpini, G., Glaser, S., Alvaro, D., Ueno, Y., Marzioni, M., Francis, H., Baiocchi, L., Stati, T., Barbaro, B., Phinizy, J.L., Mauldin, J., LeSage, G., Bile acid depletion and repletion regulate cholangiocyte growth and secretion by a phosphatidylinositol 3-kinase-dependent pathway in rats. Gastroenterology 123 (2002), 1226–1237.
9. 9 Alpini, G., Glaser, S., Ueno, Y., Rodgers, R., Phinizy, J.L., Francis, H., Baiocchi, L., Holcomb, L.A., Caligiuri, A., LeSage, G., Bile acid feeding induces cholangiocyte proliferation and secretion: evidence for bile acid-regulated ductal secretion. Gastroenterology 116 (1999), 179–186.
10. 10 Alpini, G., Ueno, Y., Glaser, S., Marzioni, M., Phinizy, J.L., Francis, H., LeSage, G., Bile acid feeding increased proliferative activity and apical bile acid transporter expression in both small and large rat cholangiocytes. Hepatology 34 (2001), 868–876.
11. 11 Mancinelli, R., Onori, P., Gaudio, E., Franchitto, A., Carpino, G., Ueno, Y., Alvaro, D., Annarale, L.P., DeMorrow, S., Francis, H., Taurocholate feeding to bile duct ligated rats prevents caffeic acid-induced bile duct damage by changes in cholangiocyte VEGF expression. Exp Biol Med 234 (2009), 462–474.
12. 12 Haselow, K., Bode, J.G., Wammers, M., Ehlting, C., Keitel, V., Kleinebrecht, L., Schupp, A.K., Haussinger, D., Graf, D., Bile acids PKA-dependently induce a switch of the IL-10/IL-12 ratio and reduce proinflammatory capability of human macrophages. J Leukoc Biol 94 (2013), 1253–1264.
13. 13 Calmus, Y., Poupon, R., Shaping macrophages function and innate immunity by bile acids: mechanisms and implication in cholestatic liver diseases. Clin Res Hepatol Gastroenterol 38 (2014), 550–556.
14. 14 Correia, L., Podevin, P., Borderie, D., Verthier, N., Montet, J.C., Feldmann, G., Poupon, R., Weill, B., Calmus, Y., Effects of bile acids on the humoral immune response: a mechanistic approach. Life Sci 69 (2001), 2337–2348.
15. 15 Scott-Conner, C.E., Grogan, J.B., The pathophysiology of biliary obstruction and its effect on phagocytic and immune function. J Surg Res 57 (1994), 316–336.
16. 16 Minter, R.M., Fan, M.H., Sun, J., Niederbichler, A., Ipaktchi, K., Arbabi, S., Hemmila, M.R., Remick, D.G., Wang, S.C., Su, G.L., Altered Kupffer cell function in biliary obstruction. Surgery 138 (2005), 236–245.
17. 17 Liedtke, C., Luedde, T., Sauerbruch, T., Scholten, D., Streetz, K., Tacke, F., Tolba, R., Trautwein, C., Trebicka, J., Weiskirchen, R., Experimental liver fibrosis research: update on animal models, legal issues and translational aspects. Fibrogenesis Tissue Repair, 6, 2013, 19.
18. 18 Chand, N., Sanyal, A.J., Sepsis-induced cholestasis. Hepatology 45 (2007), 230–241.
19. 19 Nakano, H., Fujiwara, Y., Kitamura, N., Kumada, K., Matsumiya, A., Sakai, H., Hatakeyama, T., Yamaguchi, M., Jaeck, D., Susceptibility to lipopolysaccharide of cholestatic rat liver produced with bile duct ligation: assessments of the mitochondrial glutathione pool and the effects of N-acetylcysteine. Eur Surg Res 32 (2000), 148–154.
20. 20 O'Brien, A., China, L., Massey, K.A., Nicolaou, A., Winstanley, A., Newson, J., Hobbs, A., Audzevich, T., Gilroy, D.W., Bile duct-ligated mice exhibit multiple phenotypic similarities to acute decompensation patients despite histological differences. Liver Int 36 (2016), 837–846.
21. 21 Laskin, D.L., Sunil, V.R., Gardner, C.R., Laskin, J.D., Macrophages and tissue injury: agents of defense or destruction?. Annu Rev Pharmacol Toxicol 51 (2011), 267–288.
22. 22 Sica, A., Mantovani, A., Macrophage plasticity and polarization: in vivo veritas. J Clin Invest 122 (2012), 787–795.
23. 23 Johnson, C., Han, Y., Hughart, N., McCarra, J., Alpini, G., Meng, F., Interleukin-6 and its receptor, key players in hepatobiliary inflammation and cancer. Transl Gastrointest Cancer 1 (2012), 58–70.
24. 24 Merksamer, P.I., Papa, F.R., The UPR and cell fate at a glance. J Cell Sci 123 (2010), 1003–1006.
25. 25 Schwabe, R.F., Brenner, D.A., Mechanisms of liver injury, I: TNF-α-induced liver injury: role of IKK, JNK, and ROS pathways. Am J Physiol Gastrointest Liver Physiol 290 (2006), G583–G589.
26. 26 Szabo, G., Petrasek, J., Inflammasome activation and function in liver disease. Nat Rev Gastroenterol Hepatol 12 (2015), 387–400.
27. 27 Stienstra, R., Saudale, F., Duval, C., Keshtkar, S., Groener, J.E., van Rooijen, N., Staels, B., Kersten, S., Muller, M., Kupffer cells promote hepatic steatosis via interleukin-1β-dependent suppression of peroxisome proliferator-activated receptor α activity. Hepatology 51 (2010), 511–522.
28. 28 Gieling, R.G., Wallace, K., Han, Y.P., Interleukin-1 participates in the progression from liver injury to fibrosis. Am J Physiol Gastrointest Liver Physiol 296 (2009), G1324–G1331.
29. 29 Schmidt-Arras, D., Rose-John, S., IL-6 pathway in the liver: from physiopathology to therapy. J Hepatol 64 (2016), 1403–1415.
30. 30 Salmon-Ehr, V., Ramont, L., Godeau, G., Birembaut, P., Guenounou, M., Bernard, P., Maquart, F.X., Implication of interleukin-4 in wound healing. Lab Invest 80 (2000), 1337–1343.
31. 31 Goh, Y.P., Henderson, N.C., Heredia, J.E., Red Eagle, A., Odegaard, J.I., Lehwald, N., Nguyen, K.D., Sheppard, D., Mukundan, L., Locksley, R.M., Chawla, A., Eosinophils secrete IL-4 to facilitate liver regeneration. Proc Natl Acad Sci U S A 110 (2013), 9914–9919.
32. 32 Kato, A., Yoshidome, H., Edwards, M.J., Lentsch, A.B., Reduced hepatic ischemia/reperfusion injury by IL-4: potential anti-inflammatory role of STAT6. Inflamm Res 49 (2000), 275–279.
33. 33 Gao, B., Hepatoprotective and anti-inflammatory cytokines in alcoholic liver disease. J Gastroenterol Hepatol 27 (2012), 89–93.
34. 34 Sziksz, E., Pap, D., Lippai, R., Beres, N.J., Fekete, A., Szabo, A.J., Vannay, A., Fibrosis related inflammatory mediators: role of the IL-10 cytokine family. Mediators Inflamm, 2015, 2015, 764641.
35. 35 Abe, T., Arai, T., Ogawa, A., Hiromatsu, T., Masuda, A., Matsuguchi, T., Nimura, Y., Yoshikai, Y., Kupffer cell-derived interleukin 10 is responsible for impaired bacterial clearance in bile duct-ligated mice. Hepatology 40 (2004), 414–423.
36. 36 Wan, J., Benkdane, M., Teixeira-Clerc, F., Bonnafous, S., Louvet, A., Lafdil, F., Pecker, F., Tran, A., Gual, P., Mallat, A., Lotersztajn, S., Pavoine, C., M2 Kupffer cells promote M1 Kupffer cell apoptosis: a protective mechanism against alcoholic and nonalcoholic fatty liver disease. Hepatology 59 (2014), 130–142.
37. 37 Yoshidome, H., Kato, A., Miyazaki, M., Edwards, M.J., Lentsch, A.B., IL-13 activates STAT6 and inhibits liver injury induced by ischemia/reperfusion. Am J Pathol 155 (1999), 1059–1064.
38. 38 Chiaramonte, M.G., Donaldson, D.D., Cheever, A.W., Wynn, T.A., An IL-13 inhibitor blocks the development of hepatic fibrosis during a T-helper type 2-dominated inflammatory response. J Clin Invest 104 (1999), 777–785.
39. 39 Dooley, S., ten Dijke, P., TGF-β in progression of liver disease. Cell Tissue Res 347 (2012), 245–256.
40. 40 Hara, M., Kono, H., Furuya, S., Hirayama, K., Tsuchiya, M., Fujii, H., Interleukin-17A plays a pivotal role in cholestatic liver fibrosis in mice. J Surg Res 183 (2013), 574–582.
41. 41 Ponomarev, E.D., Veremeyko, T., Barteneva, N., Krichevsky, A.M., Weiner, H.L., MicroRNA-124 promotes microglia quiescence and suppresses EAE by deactivating macrophages via the C/EBP-α-PU.1 pathway. Nat Med 17 (2011), 64–70.
42. 42 Martinez-Nunez, R.T., Louafi, F., Sanchez-Elsner, T., The interleukin 13 (IL-13) pathway in human macrophages is modulated by microRNA-155 via direct targeting of interleukin 13 receptor α1 (IL13Rα1). J Biol Chem 286 (2011), 1786–1794.
43. 43 Zhuang, G., Meng, C., Guo, X., Cheruku, P.S., Shi, L., Xu, H., Li, H., Wang, G., Evans, A.R., Safe, S., Wu, C., Zhou, B., A novel regulator of macrophage activation: miR-223 in obesity-associated adipose tissue inflammation. Circulation 125 (2012), 2892–2903.
44. 44 Yona, S., Kim, K.W., Wolf, Y., Mildner, A., Varol, D., Breker, M., Strauss-Ayali, D., Viukov, S., Guilliams, M., Misharin, A., Hume, D.A., Perlman, H., Malissen, B., Zelzer, E., Jung, S., Fate mapping reveals origins and dynamics of monocytes and tissue macrophages under homeostasis. Immunity 38 (2013), 79–91.
45. 45 Zigmond, E., Samia-Grinberg, S., Pasmanik-Chor, M., Brazowski, E., Shibolet, O., Halpern, Z., Varol, C., Infiltrating monocyte-derived macrophages and resident kupffer cells display different ontogeny and functions in acute liver injury. J Immunol 193 (2014), 344–353.
46. 46 Scott, C.L., Zheng, F., De Baetselier, P., Martens, L., Saeys, Y., De Prijck, S., Lippens, S., Abels, C., Schoonooghe, S., Raes, G., Devoogdt, N., Lambrecht, B.N., Beschin, A., Guilliams, M., Bone marrow-derived monocytes give rise to self-renewing and fully differentiated Kupffer cells. Nat Commun, 7, 2016, 10321.
47. 47 Ying, W., Cheruku, P.S., Bazer, F.W., Safe, S.H., Zhou, B., Investigation of macrophage polarization using bone marrow derived macrophages. J Vis Exp, 76, 2013, e50323.
48. +Kupffer cells recruited from bone marrow accelerate liver regeneration after partial hepatectomy. PLoS One, 10, 2015, e0136774.
49. 49 Elsegood, C.L., Chan, C.W., Degli-Esposti, M.A., Wikstrom, M.E., Domenichini, A., Lazarus, K., van Rooijen, N., Ganss, R., Olynyk, J.K., Yeoh, G.C., Kupffer cell-monocyte communication is essential for initiating murine liver progenitor cell-mediated liver regeneration. Hepatology 62 (2015), 1272–1284.
50. 50 Yang, L., Han, Z., Tian, L., Mai, P., Zhang, Y., Wang, L., Li, L., Sphingosine 1-phosphate receptor 2 and 3 mediate bone marrow-derived monocyte/macrophage motility in cholestatic liver injury in mice. Sci Rep, 5, 2015, 13423.
51. 51 Dixon, L.J., Barnes, M., Tang, H., Pritchard, M.T., Nagy, L.E., Kupffer cells in the liver. Compr Physiol 3 (2013), 785–797.
52. 52 Trivedi, P.J., Hirschfield, G.M., The immunogenetics of autoimmune cholestasis. Clin Liver Dis 20 (2016), 15–31.
53. 53 Umemura, T., Joshita, S., Ichijo, T., Yoshizawa, K., Katsuyama, Y., Tanaka, E., Ota, M., Human leukocyte antigen class II molecules confer both susceptibility and progression in Japanese patients with primary biliary cirrhosis. Hepatology 55 (2012), 506–511.
54. 54 Yayi, H., Danqing, W., Shuyun, L., Jicheng, L., Immunologic abnormality of intrahepatic cholestasis of pregnancy. Am J Reprod Immunol 63 (2010), 267–273.
55. 55 Zhang, X., Yu, L., Ding, Y., Human leukocyte antigen G and miR-148a are associated with the pathogenesis of intrahepatic cholestasis of pregnancy. Exp Ther Med 8 (2014), 1701–1706.
56. 56 Cardoso, V., Pimenta, A., da Fonseca, J.C., Rodrigues, J.S., Vaz, M.J., The effect of cholestasis on hepatic clearance of bacteria. World J Surg 6 (1982), 330–334.
57. 57 Jeyarajah, D.R., Kielar, M.L., Saboorian, H., Karimi, P., Frantz, N., Lu, C.Y., Impact of bile duct obstruction on hepatic E. coli infection: role of IL-10. Am J Physiol Gastrointest Liver Physiol 291 (2006), G91–G94.
58. 58 Lechner, A.J., Velasquez, A., Knudsen, K.R., Johanns, C.A., Tracy, T.F. Jr., Matuschak, G.M., Cholestatic liver injury increases circulating TNF-α and IL-6 and mortality after Escherichia coli endotoxemia. Am J Respir Crit Care Med 157 (1998), 1550–1558.
59. 59 Gabele, E., Froh, M., Arteel, G.E., Uesugi, T., Hellerbrand, C., Scholmerich, J., Brenner, D.A., Thurman, R.G., Rippe, R.A., TNFα is required for cholestasis-induced liver fibrosis in the mouse. Biochem Biophys Res Commun 378 (2009), 348–353.
60. 60 Sewnath, M.E., Van Der Poll, T., Ten Kate, F.J., Van Noorden, C.J., Gouma, D.J., Interleukin-1 receptor type I gene-deficient bile duct-ligated mice are partially protected against endotoxin. Hepatology 35 (2002), 149–158.
61. 61 Olteanu, S., Kandel-Kfir, M., Shaish, A., Almog, T., Shemesh, S., Barshack, I., Apte, R.N., Harats, D., Kamari, Y., Lack of interleukin-1α in Kupffer cells attenuates liver inflammation and expression of inflammatory cytokines in hypercholesterolaemic mice. Dig Liver Dis 46 (2014), 433–439.
62. 62 Sewnath, M.E., van der Poll, T., van Noorden, C.J., ten Kate, F.J., Gouma, D.J., Cholestatic interleukin-6-deficient mice succumb to endotoxin-induced liver injury and pulmonary inflammation. Am J Respir Crit Care Med 169 (2004), 413–420.
63. 63 Kopf, M., Baumann, H., Freer, G., Freudenberg, M., Lamers, M., Kishimoto, T., Zinkernagel, R., Bluethmann, H., Kohler, G., Impaired immune and acute-phase responses in interleukin-6-deficient mice. Nature 368 (1994), 339–342.
64. 64 Copple, B.L., Bai, S., Moon, J.O., Hypoxia-inducible factor-dependent production of profibrotic mediators by hypoxic Kupffer cells. Hepatol Res 40 (2010), 530–539.
65. 65 Copple, B.L., Kaska, S., Wentling, C., Hypoxia-inducible factor activation in myeloid cells contributes to the development of liver fibrosis in cholestatic mice. J Pharmacol Exp Ther 341 (2012), 307–316.
66. 66 Mochizuki, A., Pace, A., Rockwell, C.E., Roth, K.J., Chow, A., O'Brien, K.M., Albee, R., Kelly, K., Towery, K., Luyendyk, J.P., Copple, B.L., Hepatic stellate cells orchestrate clearance of necrotic cells in a hypoxia-inducible factor-1alpha-dependent manner by modulating macrophage phenotype in mice. J Immunol 192 (2014), 3847–3857.
67. 67 Zhang, S., Huang, D., Weng, J., Huang, Y., Liu, S., Zhang, Q., Li, N., Wen, M., Zhu, G., Lin, F., Gu, W., Neutralization of interleukin-17 attenuates cholestatic liver fibrosis in mice. Scand J Immunol 83 (2016), 102–108.
68. 68 Meng, F., Wang, K., Aoyama, T., Grivennikov, S.I., Paik, Y., Scholten, D., Cong, M., Iwaisako, K., Liu, X., Zhang, M., Osterreicher, C.H., Stickel, F., Ley, K., Brenner, D.A., Kisseleva, T., Interleukin-17 signaling in inflammatory, Kupffer cells, and hepatic stellate cells exacerbates liver fibrosis in mice. Gastroenterology 143 (2012), 765–776.
69. 69 Xiao, Y., Wang, J., Yan, W., Zhou, Y., Chen, Y., Zhou, K., Wen, J., Wang, Y., Cai, W., Dysregulated miR-124 and miR-200 expression contribute to cholangiocyte proliferation in the cholestatic liver by targeting IL-6/STAT3 signalling. J Hepatol 62 (2015), 889–896.
70. 70 Csak, T., Bala, S., Lippai, D., Kodys, K., Catalano, D., Iracheta-Vellve, A., Szabo, G., MicroRNA-155 deficiency attenuates liver steatosis and fibrosis without reducing inflammation in a mouse model of steatohepatitis. PLoS One, 10, 2015, e0129251.
71. 71 Arranz, A., Doxaki, C., Vergadi, E., Martinez de la Torre, Y., Vaporidi, K., Lagoudaki, E.D., Ieronymaki, E., Androulidaki, A., Venihaki, M., Margioris, A.N., Stathopoulos, E.N., Tsichlis, P.N., Tsatsanis, C., Akt1 and Akt2 protein kinases differentially contribute to macrophage polarization. Proc Natl Acad Sci U S A 109 (2012), 9517–9522.
72. 72 Nieto, N., Oxidative-stress and IL-6 mediate the fibrogenic effects of rodent Kupffer cells on stellate cells. Hepatology 44 (2006), 1487–1501.
73. 73 Fujita, T., Soontrapa, K., Ito, Y., Iwaisako, K., Moniaga, C.S., Asagiri, M., Majima, M., Narumiya, S., Hepatic stellate cells relay inflammation signaling from sinusoids to parenchyma in mouse models of immune-mediated hepatitis. Hepatology 63 (2016), 1325–1339.
74. 74 Stewart, R.K., Dangi, A., Huang, C., Murase, N., Kimura, S., Stolz, D.B., Wilson, G.C., Lentsch, A.B., Gandhi, C.R., A novel mouse model of depletion of stellate cells clarifies their role in ischemia/reperfusion- and endotoxin-induced acute liver injury. J Hepatol 60 (2014), 298–305.
75. 75 Marcos, R., Depletion of hepatic stellate cells: have Kupffer cells lost their bad neighbor?. J Hepatol 61 (2014), 714–715.
76. 76 Harty, M.W., Huddleston, H.M., Papa, E.F., Puthawala, T., Tracy, A.P., Ramm, G.A., Gehring, S., Gregory, S.H., Tracy, T.F. Jr., Repair after cholestatic liver injury correlates with neutrophil infiltration and matrix metalloproteinase 8 activity. Surgery 138 (2005), 313–320.
77. 77 Harty, M.W., Muratore, C.S., Papa, E.F., Gart, M.S., Ramm, G.A., Gregory, S.H., Tracy, T.F. Jr., Neutrophil depletion blocks early collagen degradation in repairing cholestatic rat livers. Am J Pathol 176 (2010), 1271–1281.
78. 78 Gregory, S.H., Cousens, L.P., van Rooijen, N., Dopp, E.A., Carlos, T.M., Wing, E.J., Complementary adhesion molecules promote neutrophil-Kupffer cell interaction and the elimination of bacteria taken up by the liver. J Immunol 168 (2002), 308–315.
79. 79 McDonald, B., Jenne, C.N., Zhuo, L., Kimata, K., Kubes, P., Kupffer cells and activation of endothelial TLR4 coordinate neutrophil adhesion within liver sinusoids during endotoxemia. Am J Physiol Gastrointest Liver Physiol 305 (2013), G797–G806.
80. 80 Dranoff, J.A., Wells, R.G., Portal fibroblasts: underappreciated mediators of biliary fibrosis. Hepatology 51 (2010), 1438–1444.
81. 81 Perepelyuk, M., Terajima, M., Wang, A.Y., Georges, P.C., Janmey, P.A., Yamauchi, M., Wells, R.G., Hepatic stellate cells and portal fibroblasts are the major cellular sources of collagens and lysyl oxidases in normal liver and early after injury. Am J Physiol Gastrointest Liver Physiol 304 (2013), G605–G614.
82. 82 Iwaisako, K., Jiang, C., Zhang, M., Cong, M., Moore-Morris, T.J., Park, T.J., Liu, X., Xu, J., Wang, P., Paik, Y.H., Meng, F., Asagiri, M., Murray, L.A., Hofmann, A.F., Iida, T., Glass, C.K., Brenner, D.A., Kisseleva, T., Origin of myofibroblasts in the fibrotic liver in mice. Proc Natl Acad Sci U S A 111 (2014), E3297–E3305.
83. 83 Abraham, S., Szabo, A., Kaszaki, J., Varga, R., Eder, K., Duda, E., Lazar, G., Tiszlavicz, L., Boros, M., Lazar, G. Jr., Kupffer cell blockade improves the endotoxin-induced microcirculatory inflammatory response in obstructive jaundice. Shock 30 (2008), 69–74.
84. 84 Zandieh, A., Payabvash, S., Pasalar, P., Morteza, A., Zandieh, B., Tavangar, S.M., Dehpour, A.R., Gadolinium chloride, a Kupffer cell inhibitor, attenuates hepatic injury in a rat model of chronic cholestasis. Hum Exp Toxicol 30 (2011), 1804–1810.
85. 85 Jones, C., Badger, S.A., Hoper, M., Parks, R.W., Diamond, T., Taylor, M.A., Hepatic cytokine response can be modulated using the Kupffer cell blocker gadolinium chloride in obstructive jaundice. Int J Surg 11 (2013), 46–51.
86. 86 Sturm, E., Havinga, R., Baller, J.F., Wolters, H., van Rooijen, N., Kamps, J.A., Verkade, H.J., Karpen, S.J., Kuipers, F., Kupffer cell depletion with liposomal clodronate prevents suppression of Ntcp expression in endotoxin-treated rats. J Hepatol 42 (2005), 102–109.
87. 87 Gehring, S., Dickson, E.M., San Martin, M.E., van Rooijen, N., Papa, E.F., Harty, M.W., Tracy, T.F. Jr., Gregory, S.H., Kupffer cells abrogate cholestatic liver injury in mice. Gastroenterology 130 (2006), 810–822.
88. 88 Osawa, Y., Seki, E., Adachi, M., Suetsugu, A., Ito, H., Moriwaki, H., Seishima, M., Nagaki, M., Role of acid sphingomyelinase of Kupffer cells in cholestatic liver injury in mice. Hepatology 51 (2010), 237–245.
89. 89 Iimuro, Y., Yamamoto, M., Kohno, H., Itakura, J., Fujii, H., Matsumoto, Y., Blockade of liver macrophages by gadolinium chloride reduces lethality in endotoxemic rats: analysis of mechanisms of lethality in endotoxemia. J Leukoc Biol 55 (1994), 723–728.
90. 90 Roland, C.R., Naziruddin, B., Mohanakumar, T., Flye, M.W., Gadolinium blocks rat Kupffer cell calcium channels: relevance to calcium-dependent prostaglandin E2 synthesis and septic mortality. Hepatology 29 (1999), 756–765.
91. 91 Brown, D.M., Donaldson, K., Stone, V., Role of calcium in the induction of TNFα expression by macrophages on exposure to ultrafine particles. Ann Occup Hyg 46 (2002), 219–222.
92. 92 Razzell, W., Evans, I.R., Martin, P., Wood, W., Calcium flashes orchestrate the wound inflammatory response through DUOX activation and hydrogen peroxide release. Curr Biol 23 (2013), 424–429.
93. 93 Tacke, F., Zimmermann, H.W., Macrophage heterogeneity in liver injury and fibrosis. J Hepatol 60 (2014), 1090–1096.
94. + (CD163) hepatic macrophages in rats. Hepatol Res 39 (2009), 1208–1218.
95. 95 Kinoshita, M., Uchida, T., Sato, A., Nakashima, M., Nakashima, H., Shono, S., Habu, Y., Miyazaki, H., Hiroi, S., Seki, S., Characterization of two F4/80-positive Kupffer cell subsets by their function and phenotype in mice. J Hepatol 53 (2010), 903–910.
96. + Kupffer cells/macrophages as a common cause for exacerbation of TNF/Fas-ligand-dependent hepatitis in hypercholesterolemic mice. PLoS One, 8, 2013, e49339.
97. 97 Janousek, J., Strmen, E., Gervais, F., Purification of murine Kupffer cells by centrifugal elutriation. J Immunol Methods 164 (1993), 109–117.
98. 98 Alabraba, E.B., Curbishley, S.M., Lai, W.K., Wigmore, S.J., Adams, D.H., Afford, S.C., A new approach to isolation and culture of human Kupffer cells. J Immunol Methods 326 (2007), 139–144.
99. 99 Werner, M., Driftmann, S., Kleinehr, K., Kaiser, G.M., Mathe, Z., Treckmann, J.W., Paul, A., Skibbe, K., Timm, J., Canbay, A., Gerken, G., Schlaak, J.F., Broering, R., All-in-one: advanced preparation of human parenchymal and non-parenchymal liver cells. PLoS One, 10, 2015, e0138655.
100. 100 Gehring, S., Sabo, E., San Martin, M.E., Dickson, E.M., Cheng, C.W., Gregory, S.H., Laser capture microdissection and genetic analysis of carbon-labeled Kupffer cells. World J Gastroenterol 15 (2009), 1708–1718.